🔗 Permalink

Inventor profile of:

Wilfred Jefferies

City:

Surrey

Country:

Canada

Published Applications:

Last publication date:

2025-10-23

Top Assignees for applications by Wilfred Jefferies

The entities that hold a legal rights for patent applications filed by inventor Jefferies Wilfred:

CAVA HEALTHCARE INC. 2 , Canada
Cava Healthcare Inc. 2 Vancouver, Canada
bioMmune Technologies Inc. 1 Victoria, BC Canada
The University of British Columbia 1 Vancouver, BC Canada
Alternative Extracts Inc. 1 Vancouver, Canada
CAVA HEALTHCARE INC. 1 Surrey, Canada
Bioasis Technologies, Inc. 1 Guilford, CT United States
TAPIMMUNE, INC. 1 Seattle, WA United States
Pacific Myco Biosciences, Ltd. 1 Kelowna, BC Canada
MYND LIFE SCIENCES INC. 1 Kelowna, BC Canada

Recent patent applications by Jefferies Wilfred

Wilfred Jefferies from Surrey, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-23

US20250327140A1

Chemistry; metallurgy

A METHOD OF DETERMINING THE DOSE OF PSYCHEDELICS

#2 | 2024-07-18

US20240238409A1

Human necessities

SARS-COV-2 MULTI-EPITOPE VACCINES

#3 | 2023-12-21

US20230405026A1

Human necessities

A Method of Treating Depression by Immune Modulation

#4 | 2023-12-14

US20230402129A1

Physics

A METHOD OF EPITOPE-BASED VACCINE DESIGN

#5 | 2023-07-06

US20230210832A1

Human necessities

METHODS FOR TREATING ALZHEIMER'S DISEASE

#6 | 2022-07-21

US20220226440A1

Human necessities

MODULATION OF CANCER IMMUNITY WITH TYPE 2 INNATE LYMPHOID CELLS, INTERLEUKIN 33, AND/OR INTERFERON INDUCED PROTEIN 44

#7 | 2022-04-28

US20220125876A1

Human necessities

A METHOD OF IMMUNE MODULATION BY MODULATING ABCF1

#8 | 2022-03-03

US20220062195A1

Human necessities

Curcuphenol compounds for increasing MHC-I expression

#9 | 2021-04-08

US20210100881A1

Human necessities

Methods for diagnosing and treating Alzheimer's disease

#10 | 2020-12-03

US20200375917A1

Human necessities

Curcuphenol compounds for increasing MHC-I expression

#11 | 2018-02-22

US20180050091A1

Human necessities

Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44

#12 | 2017-11-09

US20170319508A1

Human necessities

Curcuphenol compounds for increasing MHC-I expression

#13 | 2017-08-10

US20170224792A1

Human necessities

Methods for diagnosing and treating Alzheimer's disease

#14 | 2017-02-23

US20170049897A1

Human necessities

P97-polynucleotide conjugates

#15 | 2015-10-08

US20150283226A1

Human necessities

COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE

#16 | 2015-05-28

US20150147314A1

Human necessities

CURCUPHENOL COMPOUNDS FOR INCREASING MHC-I EXPRESSION

#17 | 2014-10-02

US20140294726A1

Human necessities

METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANTI-ANGIOGENIC AGENT

#18 | 2011-05-19

US20110117137A1

Human necessities

TAPASIN AUGMENTATION FOR ENHANCED IMMUNE RESPONSE

InventorID:

920527 ⎘